Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Empagliflozin reduced the combined risk of cardiovascular death or hospitalization for heart failure in patients with heart failure and a preserved ejection fraction, regardless...
Publications
3 shownAntiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Antiinflammatory therapy targeting the interleukin-1β innate immunity pathway with canakinumab at a dose of 150 mg every 3 months led to a significantly lower rate of recurrent ...
Frequent Co-Authors
Researcher Info
- h-index
- 3
- Publications
- 3
- Citations
- 23,778
- Institution
- Charité - Universitätsmedizin Berlin
External Links
Identifiers
- ORCID
- 0000-0002-0805-8683
Impact Metrics
h-index
3
h-index: Number of publications with at least h citations each.